Childrens Plus Flu Suspension
NDC Package 55910-031-04

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Childrens Plus Flu (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrobromide, phenylephrine hci) suspension is this product does not contain directions or complete warnings for adult use.mL =millilitershake well before usingmeasure only with dosing cup provideddo not use with any other dosing devicekeep dosing cup with product do not give more than 5 times in 24 hoursif needed, repeat dose every 4 hours while symptoms lastfind the right dose on chart below. This formulation utilizes a suspension delivery system. Marketed by Dolgencorp, Inc. (dollar General & Rexall), this product is identified by NDC 55910-031 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
55910-031-04
Package Description
1 BOTTLE, PLASTIC in 1 BOX / 118 mL in 1 BOTTLE, PLASTIC
Product Code
55910-031
11-Digit Billing Format
55910003104
RxNorm Crosswalk
  • RxCUI: 1113397 - acetaminophen 160 MG / chlorpheniramine maleate 1 MG / dextromethorphan HBr 5 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Suspension
  • RxCUI: 1113397 - acetaminophen 32 MG/ML / chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Suspension
  • RxCUI: 1113397 - acetaminophen 160 MG / chlorpheniramine maleate 1 MG / dextromethorphan HBr 5 MG / phenylephrine HCl 2.5 MG per 5 ML Oral Suspension
  • RxCUI: 1113397 - APAP 32 MG/ML / Chlorpheniramine Maleate 0.2 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / Phenylephrine Hydrochloride 0.5 MG/ML Oral Suspension

Clinical Specifications

Proprietary Name
Childrens Plus Flu
Non-Proprietary Name
Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hci
Substance Name
Acetaminophen; Chlorpheniramine Maleate; Dextromethorphan Hydrobromide; Phenylephrine Hydrochloride
Dosage Form
Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
This product does not contain directions or complete warnings for adult use.mL =millilitershake well before usingmeasure only with dosing cup provideddo not use with any other dosing devicekeep dosing cup with product do not give more than 5 times in 24 hoursif needed, repeat dose every 4 hours while symptoms lastfind the right dose on chart below. If possible, use weight to dose: otherwise usWeight (lb)Age (yr)Dose ( mL) 48-95 6-11 10 mL 36-47 4-5 do not use unless directed by a doctor under 36 under 4 do not use

Regulatory & Marketing

Labeler Name
Dolgencorp, Inc. (dollar General & Rexall)
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-31-2015
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55910-031-04 identifies a specific commercial package of 1 bottle, plastic in 1 box / 118 ml in 1 bottle, plastic of Childrens Plus Flu, a human over the counter drug labeled by Dolgencorp, Inc. (dollar General & Rexall). This suspension is formulated for oral use and contains acetaminophen; chlorpheniramine maleate; dextromethorphan hydrobromide; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dolgencorp, Inc. (dollar General & Rexall) on May 31, 2015. The current certification is valid through December 31, 2026.

How is this Dolgencorp, Inc. (dollar General & Rexall) product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55910003104. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55910-031-04
11-Digit CMS (5-4-2)
55910-0031-04

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.